Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Pharmacol Ther. 2016 Jun 29;166:30–39. doi: 10.1016/j.pharmthera.2016.06.010

Table 1.

Defining characteristics of CARs and TCRs

Chimeric antigen receptors (CARs) T cell receptors (TCRs)
Signal amplification Determined by synthetic biology Determined by evolution
Affinity High and can be engineered Low but can be enhanced
Target Cell surface proteome Intracellular proteome
MHC dependency Independent Required
Safety Toxicities possible due to antigen expression on normal tissues Toxicities may be difficult to predict
Mechanisms of resistance Antigen loss Antigen loss, MHC loss/downregulation, defects in antigen presentation
HHS Vulnerability Disclosure